CompletedPhase 2/3

Prospective Study to Determine the Effect of Subconjunctival Bevacizumab (AVASTIN) in Corneal Neovascularization

Mexico18 participantsStarted 2006-09

Plain-language summary

To determine the effect of subconjunctival Bevacizumab in corneal neovascularization

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Presence of vessels in minimum one quadrant
✓. vessels that penetrate more than 0.5 mm of the limb, in any depth
✓. who had signed the informed consent
✓. those that could attend to frequent ophthalmologic revisions after treatment and could wait for 6 months before the surgical procedure.

✕. Patients with urgent need of a penetrating keratoplasty, pregnancy or lactancy
✕. Patient that may need an additional procedure to penetrating keratoplasty.

Anterior segment slit-lamp photographs and fluorescein angiograms Compared for any sign of diminished vascularization

Timeframe: three weeks after treatment

NCT IDNCT00555594

SponsorAsociación para Evitar la Ceguera en México

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2006-09